Search for Clinical Trial Results
Neuromyelitis Optica - 57 Studies Found
Status | Study |
Recruiting |
Study Name: Hematopoietic Stem Cell Transplant in Devic's Disease Condition: Devic's Disease Date: 2008-10-31 Interventions: Procedure: Hematopoietic stem cell transplantation Mobiliz |
Recruiting |
Study Name: Efficacy and Safety Study as Monotherapy of SA237 to Treat NMO and NMOSD Condition: Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD) Date: 2014-02-25 Interventions:
|
Recruiting |
Study Name: Efficacy and Safety Study as Add-on Therapy of SA237 to Treat NMO and NMOSD Condition:
|
Enrolling by invitation |
Study Name: Mycophenolate Mofetil Treatment With Neuromyelitis Optica Spectrum Disorders in Chinese Patients Condition:
|
Enrolling by invitation |
Study Name: Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders Condition:
|
Completed |
Study Name: Phase II Clinical Trial of NPB-01 in Patients With Anti-aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorder Not Provided Adequate Effect of Therapy to Steroids Plus Therapy. Condition: Neuromyelitis Optica Spectrum Disorder Date: 2013-04-26 Interventions: Drug: NPB-01 Other Name: Intravenous immunoglobulin |
Active, not recruiting |
Study Name: Efficacy and Safety of Bortezomib as add-on Treatment in Relapsing Neuromyelitis Optica Spectrum Disorder Condition: Neuromyelitis Optica Spectrum Disorder Date: 2016-08-27 Interventions: Drug: Bortezomib Bortezomib will be subcutaneously applicated in 4 treatment cycles with 4 injections of |
Recruiting |
Study Name: A Double-masked, Placebo-controlled Study With Open Label Period to Evaluate MEDI-551 in Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders Condition: Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders (NMO/NMOSD) Date: 2014-07-16 Interventions:
|
Active, not recruiting |
Study Name: Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses Condition:
|
Active, not recruiting |
Study Name: Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders Condition:
|